PK MED receives a non-dilutive DeepTech grant of 1.5 million Euros from Bpifrance for the development of a local cell homing implant to enhance bone marrow transplantation.
Amount Raised
€1.5 Million
Round Type
Grant
ParisBiotechnologyHealth CareInvestors
Description
PK MED, a privately owned French biotechnology company founded in 2019 by Truffle Capital, announced the receipt of a non-dilutive DeepTech grant of 1.5 million Euros from Bpifrance. The funding will accelerate the company's project PKM-02, which involves an innovative cell homing technology aimed at improving bone marrow transplantation for diseases with high medical needs such as leukemias and hemoglobinopathies.
Quick answer
PK MED raised €1.5 Million in a Grant round, dated July 24, 2024. Investors: Bpifrance. PK MED is based in Paris, Ile-de-France, France.
- How much did PK MED raise?
- PK MED raised €1.5 Million in a Grant round on July 24, 2024.
- Who invested in PK MED?
- Bpifrance is named as investors in this round.
- What does PK MED do?
- PK MED is a French biotechnology company founded in 2019 by Truffle Capital, specializing in developing injectable smart implants for drug release in rheumatology and cell homing in bone marrow transplantations.
- Where is PK MED based and how big is it?
- PK MED is based in Paris, Ile-de-France, France. Fundz records about 10 employees.
- Who are the decision-makers at PK MED?
- Fundz holds 1 contact at PK MED. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as PK MED that raised within 45 days of this round, from Fundz verified event records.
- TippingPoint Biosciences raised an undisclosed amount (Pre-Seed) on September 5, 2024.
- HDAX Therapeutics raised $3.2M (Seed) on September 5, 2024.
- PatientPartner raised $7M (Seed) on September 4, 2024.
- HEPTA Medical raised $6.3M (Series A) on September 4, 2024.
- Arsenal Biosciences raised $325M (Series C) on September 4, 2024.
- Safe Superintelligence raised $1B (Convertible Note) on September 4, 2024.
Who to call at PK MED, and when
A new round usually means PK MED is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PK MED raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PK MED, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PK MED. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PK MED raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PK MED raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.